欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号NL/H/3888/002
药品名称Eptifibatide AFTPharm 2 mg/ml oplossing voor injectie
活性成分
    • Eptifibatide 0.75 mg/ml
剂型Solution for infusion
上市许可持有人AFT Pharmaceuticals (EUR) Limited Sinnottstown Business Park Sinnottstown Lane Drinagh Wexford Y35 AKX5 Ierland
参考成员国 - 产品名称Netherlands (NL)
互认成员国 - 产品名称
    • Germany (DE)
    • Denmark (DK)
      Eptifibatide Ctruz
    • Ireland (IE)
    • Italy (IT)
    • Sweden (SE)
    • Norway (NO)
    • Finland (FI)
许可日期2017/12/14
最近更新日期2025/08/21
药物ATC编码
    • B01AC16 eptifibatide
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Additional Strength/Form
  • TypeLevel3:Generic Art 10.1 and 10.2 Dir 2001/83/EC
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
市场状态Positive
©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase